The above chart listing is from a Pfizer-BioNTech document obtained via FOIA, showing the IgG binding results of a few of the C4591001 human test subjects for the company’s “flagship” COVID-19 “vaccine”, BNT162b2. The document was given to the FDA on 19 September 2020. BNT162b2 was granted the initial EUA for use in the United States in December 2020.

This series on the disaster of COVID-19 and the COVID-19 “vaccines” is dedicated to Yours Truly’s cousin Bill, who “died suddenly and unexpectedly” in September 2023.

Today’s offering will present and discuss some aspects of the emergence of “turbo-cancers” that appear in people who get injections of the COVID-19 “vaccines” (actually, gene therapy shots.) Today’s presentation is not an “magnum opus” compilation, but rather an adjunct to more understanding of the issue. It will not discuss the presence of the SV40 cancer promoter code that was discovered recently in the modRNA COVID-19 “vaccines” — that is an issue to be addressed in another post. What will be presented today is the role of IgG4-engendered cancer onset and/or relapse due to “vaccination” by the modRNA COVID-19 “vaccines.”

Without “wearying by recitals”, the story begins with a short presentation on the Ig system of the human body. This system consists of five different Ig cell types: IgM; IgD; IgA; IgE, and IgG. IgA and IgG cells can be divided into subclasses. What are called “subclass switches” within the IgA class and IgG class are regulated via interaction with the T cells of the human body. The Ig system is basically an infection-fighter system. It needs to be in balance in order for this work to be successfully performed. Imbalances of the Ig system can result in the incidence of various medical disease conditions, such as autoimmune diseases and asthma. Some people have inherited imbalances of their Ig system. Today’s offering will confine itself to the IgG class.

The IgG class of cells can be divided into four separate subclasses: IgG1; IgG2; IgG3; and IgG4. Robert H. Pointer wrote the following regarding the IgG class in general: “Firstly, IgG neutralizes pathogens such as viruses and bacteria by binding to key pathogen surface proteins and preventing interaction of the pathogen with host cells. In doing so, the antibody [of the IgG cell] neutralizes the ability of the pathogen to enter host cells and replicate.” (Encyclopedia of Immunology, Second Edition, 1998, “Immunoglobulin G” chapter; bolding is mine.)

Please read those two sentences above by Prof. Pointer again. Now look again at the chart at the top of today’s offering, which shows the high binding ability of the Pfizer-BioNTech modRNA COVID-19 “vaccine”, BNT162b2, to the cells of the human subjects who took this “vaccine” in the C4591001 clinical trial of said “vaccine.” This is the same BNT162b2 “vaccine” formula that was granted the initial EUA by the FDA in December 2020 for use in the United States. It is also the same BNT162b2 “vaccine” formula (under both the name, “Pfizer-BioNTech COVID-19 Vaccine” and under the name, “COMIRNATY”) that was used in the United States until the spring of 2023, at which time it was removed from use in this country and was substituted with the “2023-2024 Formula COVID-19 Vaccine” by the same company. BNT162b2 is still used in other countries. It appears that two of the main goals of BNT162b2 (a modRNA COVID-19 “vaccine”) were, and are (both in the BNT162b2 “vaccine”, AND in the basic formulation of the current “2023-2024 Formula COVID-19 Vaccine”), to evade the “vaccine” recipient’s natural IgG class cells’ “detection and fight” capability; and, to compromise the “vaccine” recipient’s natural IgG class cells’ ability to DENY ACCESS to the “vaccine” into the cells of the recipient’s body (this, via the use of the lipid nanoparticles ALC-0159 and ALC-0315 in these “vaccines.”),

Yours Truly now turns to https://jessicar.substack.com/p/igg4-and-cancer-a-mechanism-of-action, “IgG4 and cancer – a mechanism of action for cancer relapse and onset”, published on 30 December 2022. Dr. Rose describes how IgG4 class cells can, by “class switching” (also called “Fab Arm Exchange”) due to chronic exposure to an antigen, literally “turn around” their normal antibody function of tumor suppression into tumor progression. Dr. Rose then goes on to discuss this phenomenon in light of the modRNA COVID-19 “vaccines” and how these injections introduce “highly immunogenic protein” into the body of the “vaccine” recipient, which then induces “continuous antigen stimulation by the injectables’ contents and their by-products” (Italics mine.) She ends her article with: “My take home message: This could be potentiating relapses of cancers previously in remission and also new and rare cancer appearances.” In my opinion, this is particularly troubling, since nobody really knows how long the modRNA, the spike protein, and the ALC-0159 and ALC-0315 lipid nanoparticles remain in the “vaccine” recipient’s body; especially if that “vaccine” recipient continues to get modRNA COVID-19 “vaccine booster shots” to “complete a catch-up series”, or the “2023-2024 Formula COVID-19 Vaccine” made by Pfizer-BioNTech and also by Moderna.

We now turn to the work of Dr. Ryan Cole, the pathologist. He has been sounding the alarm over the presence of turbo-cancers in his modRNA COVID-19 “vaccinated” patients for over a year (and for which, he is now fighting the “professional misconduct charges” that were served against him by the Washington State medical licensing board. Please refer to https://vigilantnews.com/post/turbo-death-from-turbo-cancers-were-in-trouble-says-dr-ryan-cole, from 10 October 2023. Dr. Cole makes it clear that the “vaccines” do not actually cause cancer; they “cause immune suppression. They cause a disruption and a dysregulation of your immune system that normally is what would fight cancer.” (Another way, in my opinion, of saying the IgG4 “class switch” induced by the modRNA COVID-19 “vaccines” that turns this class of cells’ normal function of fighting tumors into, instead, allowing tumors to grow.)

The “Vidarsson paper” from 2014 describes the IgG subclasses, what they do, and what can happen when one or more of these subclasses are either deficient or increased too much: www.frontiersin.org/articles/10.3389/fimmu.2014.00520/full, “IgG subclasses and allotypes: from structure to effector functions”, Gestur Vidarsson et al. Please see the section “IgG4” about how the IgG4 subclass works; and the section “IgG4 Fab Arm Exchange.”

IgG4 cells will also change in the unborn child and in its pregnant mother due to modRNA COVID-19 “vaccination.” Here is a graphic showing these changes:

The above graphic is from here: https://doi.org/10.1101/2023.05.01.538955, “Diverging maternal and infant cord antibody functions from SARS-CoV-2 infection and vaccination in pregnancy”, Emily H. Adhikari, et al. From the Introduction: “After mRNA vaccination [of the pregnant mother], the primary form of immunity transferred to the fetus is antibodies, specifically IgG.” (Bolding mine)

Two blog posts by Igor Chudov provide more information. The first is from 21 October 2022: www.igor-chudov.com/p/cancer-rates-are-increasing-and-may, “Cancer Rates are Increasing — and May Get Much Worse.” In this post, Mr. Chudov discusses the 9-sigma increase in cancer rates in the United States and a similar rise in the UK. At the time of this post (a little over one year ago), there was suspicion regarding the reason why the modRNA COVID-19 “vaccines” were engendering an increase in cancer diagnoses: the suspicions rested on the use of the “faux” pseudouridine in the “vaccines”; the discovery of “loose DNA” in the “vaccines”; and the genotoxicity of the spike protein itself. By December, 2022, Mr. Chudov was on the trail of the IgG4-induced immune system damage engendered by the “vaccines”: www.igor-chudov.com/p/booster-caused-immune-tolerance-explains, “Booster-Caused IgG4 Immune Tolerance Explains Excess Mortality and “Chronic Covid.” Here, the following paper was referenced regarding the IgG4 “class switch”: www.science.org/doi/10.1126/sciimmunol.ade2798, “Class switch towards non-inflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination”, Pascal Irrgang et al. (In other words, a “class switch” to the “tolerate but don’t clear” IgG4 cells.) The latest post by Mr. Chudov on the issue, that is very specific, is from 26 November 2023: www.igor-chudov.com/p/hyperprogressive-cancers-due-to-covid, “‘Hyperprogressive’ Cancers Due to COVID-Vaccine-Caused IgG4 Antibodies.” The take away from this post: “…IgG4 drives malignancy and aggressiveness of the real-life cancers they observed.” Here is a graphic from Mr. Chudov’s post, taken from this paper: https://jitc.bmj.com/content/8/2/e000661, “An immune evasion mechanism with IgG4 playing an essential role in cancer and implication for immunotherapy”, Hui Wang et al.

Finally, there is this: https://doi.org/10.1016/j.mehy.2023.111015, “Potential health risks of mRNA-based vaccine therapy: A hypothesis”, by K. Acevedo-Whitehouse and R. Bruno, published on 25 January 2023. It appears that an important key to understanding the mechanisms of the modRNA COVID-19 “vaccines” that can induce sufficient immune system suppression in the “vaccinated” person’s body it that these “vaccines” employ N1-methylpseudouridine. (This ingredient “evades” the body’s natural “immune system defense mechanism.”) The paper also discusses “other contaminants” in the “vaccines” that “…could further alter immune recognition and deregulate immune signalling pathways,…it is not unreasonable to assume that mRNA-based vaccines could induce sustained inflammation and a persistent anti-viral cellular state in various tissues.” (Italics mine) Yours Truly is including a graphic from the paper of what the synthetic RNA “vaccines” do to the cells of the “vaccine” recipient:

Now, as to the COVID-19 virus itself: There are elements within the virus itself that can cause immune system damage; that can change, damage, or destroy B-cells and CD-class cells in the body of the person who contracts a case of the virus; and may have other elements that can pave the way for cancer tumor onset or relapse. Yours Truly refers to this paper, from September 2020 (this was when BNT162b2 was in “clinical trials”): https://doi.org/10.1126/science.abc8511, “Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications”, Divij Matthew et al. Prof. Matthew and his colleagues demonstrate concerning changes in B-cells and CD8 cells in certain COVID-19 infected patients. Certain immunotypes among the patients studied were more affected than others. From the Abstract: “Whereas immunoglobulin G (IgG) levels reportedly drop slightly ~8 weeks after symptom onset (24, 25), recovered patients maintain high spike protein-specific IgG titers (6, 26).” (Bolding mine)

Another view of the toxic properties of the COVID-19 virus itself, especially regarding the inducement of cancer, is here: https://wmcresearch.substack.com/p/sars-cov-2-the-spike-protein-and, “SARS-CoV-2, the Spike Protein and Oncogenesis”, published on 2 November 2023. Walter M. Chesnut discusses his conclusion that the SARS-CoV-2 virus itself, plus its spike protein, change ALL the following body functions: DNA Repair; Cell Division; Apoptosis (natural cell death); Cellular Differentiation; and Cell-Cell Contact/Communication.

So, if the COVID-19 virus itself and its spike protein have properties that can engender the circumstances for cancer tumor onset, growth, and/or relapse, what makes the modRNA COVID-19 “vaccines” even more dangerous in this regard? One will point to the use of the ALC-0159 and ALC-0315 lipid nanoparticles in these “vaccines”, which facilitate entry of the “vaccine” ingredients to every cell of the recipient’s body; and, to the use of the N1-methylpseudouridine in these “vaccines” which “evade” the natural “enemy detection and destruction” processes of the “vaccine” recipient’s body.

In Yours Truly’s opinion, it took time, effort, and detailed investigation, to lab-create the SARS-CoV-2 (COVID-19) virus itself and its spike protein; and, it took time, effort, and detailed investigation, to lab-create and assemble the ingredients (including the COVID-19 virus itself, and its spike protein) that were, and are, present in the modRNA COVID-19 “vaccines.” The FDA knew, back in the summer of 2020, and certainly on 30 April 2021, how dangerous the modRNA COVID-19 “vaccine” BNT162b2 was, and is. Please refer to: www.phmpt.org/wp-content/uploads/2022/04/reissue_5.3.6-postmarketing-experience.pdf, FDA time-stamped on 30 April 2021. In fact, the FDA, on that date, knew that at least one IgG4 “class switch” condition was occurring in BNT162b2 “vaccinated” persons — Thrombotic thrombocytopenic purpura (an IgG4 autoimmune disease), listed on page 38 of the report.

Of course, cancer can, and does, occur for other reasons than being engendered by COVID-19 “vaccination” or infection. There are many contributing factors — from genetic predisposition to smoking to accumulated immune system dysfunction, among others. However, while it can be fairly argued that the COVID-19 virus itself, with its spike protein, AND the modRNA COVID-19 “vaccines” based on said virus and its spike protein can, and do, engender cancer tumor growth and/or relapse — the modRNA COVID-19 “vaccines” are more dangerous in this regard. One can posit that it may be valuable for people to learn about family members have/had cancer; what history of cancer “runs in the family”, if any; about family members who have/had immune system issues; and so on. It is absolutely valuable for all people to be in, and remain in, the best physical shape and the best mental-health shape possible. It is absolutely valuable to follow a COVID-19 prevention/prophylaxis protocol.

The compendium post regarding the COVID-19 virus and the modRNA COVID-19 “vaccines”, for further reference: www.theqtree.com/2023/11/20/the-covid-19-vaccines-are-dangerous-and-a-caveat-about-the-virus-itself/

Peace, Good Energy, Respect: PAVACA